Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.10.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Basic and diluted numerator:    
Net loss attributable to iBio, Inc. stockholders $ (4,398) $ (3,826)
Preferred stock dividends (66) (66)
Net loss available to iBio, Inc. stockholders $ (4,464) $ (3,892)
Basic and diluted denominator:    
Weighted-average common shares outstanding 17,894 9,185
Per share amount $ (0.25) $ (0.42)